Molecular Docking Study of Anti-viral FDA-approved Drugs as Novel Entry and Replication Ebola Viral Inhibitors

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Adhami V.; SEPEHRI S.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF ADVANCED BIOMEDICAL SCIENCES Year:2019 | Volume:9 | Issue:1 Page(s): 1257-1266

Download Full-Text

Persian Verion

View:

723

Download:

Cites:

Information Journal Paper

Title

Molecular Docking Study of Anti-viral FDA-approved Drugs as Novel Entry and Replication Ebola Viral Inhibitors

Author(s)

Adhami V. | SEPEHRI S. | Issue Writer Certificate

Keywords

DockingQ1

Ebola viralQ1

Drug repositioningQ1

VP40Q1

GPQ1

Abstract

Background & Objective: Because of the reported high ability of virulence and the lack of appropriate drug of Ebola virus during the last decades, many investigations have been accomplished regarding discovery and the introduction of anti-Ebola drugs. The aim of this research was the bioinformatical study of entry and replication of Ebola viral inhibition by drug repurposing. Materials & Methods: It is a descriptive-analytic study. In order to investigate the mode of interaction of the compounds with GP and VP40 binding sites, the chemical structures of all compounds were designed using ChemDraw program, then were transferred into Hyperchem software for energy minimization. Molecular Docking simulation was accomplished using AutoDock 4. 2 program. Results: Docking results revealed the hydrophobic, hydrogen bond, π-π and π-cation contacts were involved in the drug-protein interactions. Among all the studied drugs, the best Docking results were related to Amodiaquine and Diphenoxylate drugs displayed. Actually, this compounds had the most negative Δ Gbinding that indicated suitable modes and favorable interactions with the amino acid residues at the binding site of GP and VP40. The weakest Docking results were exhibited for Dirithromycin and Erythromycin drugs due to the high hydrophilic character of them. In general, the presence of hydrophobic portions, tertiary amines, and optimal hydrogen bonds increases the strength of anti-Ebola medications. Conclusion: According to the results of the molecular Docking, the entire FDA-approved drugs revealed a good inhibition effect on entry and replication Ebola viral.

Cites

No record.

References

Cite

APA: Copy

Adhami, V., & SEPEHRI, S.. (2019). Molecular Docking Study of Anti-viral FDA-approved Drugs as Novel Entry and Replication Ebola Viral Inhibitors. JOURNAL OF ADVANCED BIOMEDICAL SCIENCES, 9(1 ), 1257-1266. SID. https://sid.ir/paper/365846/en

Vancouver: Copy

Adhami V., SEPEHRI S.. Molecular Docking Study of Anti-viral FDA-approved Drugs as Novel Entry and Replication Ebola Viral Inhibitors. JOURNAL OF ADVANCED BIOMEDICAL SCIENCES[Internet]. 2019;9(1 ):1257-1266. Available from: https://sid.ir/paper/365846/en

IEEE: Copy

V. Adhami, and S. SEPEHRI, “Molecular Docking Study of Anti-viral FDA-approved Drugs as Novel Entry and Replication Ebola Viral Inhibitors,” JOURNAL OF ADVANCED BIOMEDICAL SCIENCES, vol. 9, no. 1 , pp. 1257–1266, 2019, [Online]. Available: https://sid.ir/paper/365846/en

Related Journal Papers